Patent · US Active

Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives

US11931328B2 · kind B2 · utility

0Cited by

20References

18Claims

0Family size

Assignee

AMNEAL PHARMACEUTICALS LLC · US

Inventors

David Penake · San Francisco, US
Sharon Hamm · Land O' Lakes, US
Leonard O'Mahony · Mullingar, IE
John Devane · Dublin, IE
Wolfgang Mohr · Freiburg (Elbe), DE
Manuel Weinheimer · Neustadt an der Weinstraße, DE

Key dates

Filing date	Mar 16, 2023
Grant date	Mar 19, 2024
Priority date	—
Expiry date	Mar 16, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions including an active ingredient and a stabilizer, as well as methods of manufacture of the compositions, and methods of their use. The composition may include the active ingredient dispersed throughout a matrix of the stabilizer. In some embodiments, the active ingredient and the stabilizer are intimately mixed in a matrix formulation. In some embodiments, the active ingredient is selected from 4 amino-3-(4-chlorophenyl)butanoic acid) (“baclofen”) and its pharmaceutically acceptable salts.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.